Pro-inflammatory interactions of streptolysin O toxin with human neutrophils in vitro

References

• [WHO] World Health Organization. 2022. Increased incidence of scarlet fever and invasive Group A streptococcus infection - multi-country. https://www.who.int/europe/news/item/12-12-2022.
   Google Scholar
• Akuzawa N, Kurabayashi M. 2016. Bacterial pneumonia caused by Streptococcus pyogenes infection: A case report and review of the literature. J Clin Med Res. 8(11):831–835. doi:10.14740/jocmr2737w.
   PubMedGoogle Scholar
• Andersen B, Duncan J. 1980. Activation of human neutrophil metabolism by streptolysin O. J Infect Dis. 141(5):680–685. doi:10.1093/infdis/141.5.680.
   PubMed Web of Science ®Google Scholar
• Bamford A, Whittaker E. 2023. Resurgence of Group A streptococcal disease in children. BMJ. 380:43. doi:10.1136/bmj.p43.
   PubMedGoogle Scholar
• Beatty K, Robertie P, Senior R, Travis J. 1982. Determination of oxidized aα-1-proteinase inhibitor in serum. J Lab Clin Med. 192(2):186–192.
   Google Scholar
• Branzk N, Papayannopoulos V. 2013. Molecular mechanisms regulating NETosis in infection and disease. Semin Immunopathol. 35(4):513–530. doi:10.1007/s00281-013-0384-6.
   PubMed Web of Science ®Google Scholar
• Brouwer S, Rivera-Hernandez T, Curren B, Harbison-Price N, de Oliveira D, Jespersen M, Davies M, Walker M. 2023. Pathogenesis, epidemiology and control of Group A Streptococcus infection. Nat Rev Microbiol. 21(7):431–447. doi:10.1038/s41579-023-00865-7.
   PubMed Web of Science ®Google Scholar
• Clarke J, Baltazar M, Alsahag M, Panagiotou S, Pouget M, Paxton W, Pollakis G, Everett D, French N, Kadioglu T. 2021. Streptolysin O concentration and activity is central to in vivo phenotype and disease outcome in Group A Streptococcus infection. Sci Rep. 11(1):19011. doi:10.1038/s41598-021-97866-4.
   PubMed Web of Science ®Google Scholar
• Cockeran R, Theron A, Steel H, Matlola N, Mitchell T, Feldman C, Anderson R. 2001. Pro-inflammatory interactions of pneumolysin with human neutrophils. J Infect Dis. 183(4):604–611. doi:10.1086/318536.
   PubMed Web of Science ®Google Scholar
• Döhrmann S, Cole J, Nizet V. 2016. Conquering neutrophils. PLoS Pathog. 12(7):e1005682. doi:10.1371/journal.ppat.1005682.
   PubMed Web of Science ®Google Scholar
• Escajadillo T, Nizet V. 2018. Pharmacological targeting of pore-forming toxins as adjunctive therapy for invasive bacterial infection. Toxins (Basel). 10(12):542. doi:10.3390/toxins10120542.
   PubMed Web of Science ®Google Scholar
• Grynkiewicz G, Poenie M, Tsien R. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 260(6):3440–3450.
   PubMed Web of Science ®Google Scholar
• Hudock KM, Collins MS, Imbrogno M, Snowball J, Kramer EL, Brewington JJ, Gollomp K, McCarthy C, Ostmann AJ, Kopras EJ, et al. 2020. Neutrophil extracellular traps activate IL-8 and IL-1 expression in human bronchial epithelia. Am J Physiol Lung Cell Mol Physiol. 319(1):L137–L147. doi:10.1152/ajplung.00144.2019.
   PubMed Web of Science ®Google Scholar
• Letsiou E, Alves L, Felten M, Mitchell T, Müller-Redetzky H, Dudek S, Witzenrath M. 2021. Neutrophil-derived extracellular vesicles activate platelets after pneumolysin exposure. Cells. 10(12):3581. doi:10.3390/cells10123581.
   PubMed Web of Science ®Google Scholar
• Li H, Zhi X, Viera A, Whitwell H, Schricker A, Jauneikaite E, Li H, Yosef A, Andrew I, Game L. 2023. Characterization of emergent toxigenic M1UK Streptococcus pyogenes and associated sub-lineages. Microb Genom. 9(4):mgen000994.
   PubMed Web of Science ®Google Scholar
• Limbago B, Penumalli V, Weinrick B, Scott J. 2000. Role of streptolysin O in a mouse model of invasive Group A Streptococcal disease. Infect Immun. 68(11):6384–6390. doi:10.1128/IAI.68.11.6384-6390.2000.
   PubMed Web of Science ®Google Scholar
• Minkenberg I, Ferber E. 1984. Lucigenin-dependent chemiluminescence as a new assay for NADPH-oxidase activity in particulate fractions of human polymorphonuclear leukocytes. J Immunol Methods. 71(1):61–67. doi:10.1016/0022-1759(84)90206-0.
   PubMed Web of Science ®Google Scholar
• Nel J, Theron A, Durandt C, Tintinger G, Pool R, Mitchell T, Feldman C, Anderson R. 2016. Pneumolysin activates neutrophil extracellular trap formation. Clin Exp Immunol. 184(3):358–367. doi:10.1111/cei.12766.
   PubMed Web of Science ®Google Scholar
• Ochi F, Tauchi H, Jogamoto T, Miura H, Moritani T, Nagai K, Ishii E. 2018. Sepsis and pleural empyema caused by Streptococcus pyogenes after influenza A virus infection. Case Rep Pediatr. 2018:4509847. doi:10.1155/2018/4509847.
   PubMedGoogle Scholar
• Parks T, Barrett L, Jones N. 2015. Invasive streptococcal disease: A review for clinicians. Br Med Bull. 115(1):77–89. doi:10.1093/bmb/ldv027.
   PubMed Web of Science ®Google Scholar
• Richter J, Monteleone M, Cork A, Barnett T, Nizet V, Brouwer S, Schroder K, Walker M. 2021. Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection. Immunol Cell Biol. 99(10):1040–1052. doi:10.1111/imcb.12499.
   PubMed Web of Science ®Google Scholar
• Sierig G, Cywes C, Wessels M, Ashbaugh C. 2003. Cytotoxic effects of streptolysin O and streptolysin S enhance the virulence of poorly encapsulated Group A Streptococci. Infect Immun. 71(1):446–455. doi:10.1128/IAI.71.1.446-455.2003.
   PubMed Web of Science ®Google Scholar
• Soehnlein O, Oehmcke S, Ma X, Rothfuchs AG, Frithiof R, van Rooijen N, Mörgelin M, Herwald H, Lindbom L. 2008. Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur Respir J. 32(2):405–412. doi:10.1183/09031936.00173207.
   PubMed Web of Science ®Google Scholar
• Sørensen OE, Borregaard N. 2016. Neutrophil extracellular traps - the dark side of neutrophils. J Clin Invest. 126(5):1612–1620. doi:10.1172/JCI84538.
   PubMed Web of Science ®Google Scholar
• Tamayo E, Montes M, Vicente D, Pérez-Trallero E. 2016. Streptococcus pyogenes pneumonia in adults: clinical presentation and molecular characterization of isolates 2006-2015. PLoS One. 11(3):e0152640. doi:10.1371/journal.pone.0152640.
   PubMed Web of Science ®Google Scholar
• Uchiyama S, Döhrmann S, Timmer AM, Dixit N, Ghochani M, Bhandari T, Timmer JC, Sprague K, Bubeck-Wardenburg J, Simon SI, et al. 2015. Streptolysin O rapidly impairs neutrophil oxidative burst and antibacterial responses to Group A Streptococcus. Front Immunol. 6:581. doi:10.3389/fimmu.2015.00581.
   PubMed Web of Science ®Google Scholar
• Vorobjeva N, Chernyak B. 2020. NETosis: Molecular mechanisms, role in physiology and pathology. Biochemistry (Mosc). 85(10):1178–1190. doi:10.1134/S0006297920100065.
   PubMed Web of Science ®Google Scholar
• Walker M, Barnett T, McArthur J, Cole J, Gillen C, Henningham A, Sriprakash K, Sanderson-Smith M, Nizet V. 2014. Disease manifestations and pathogenic mechanisms of Group A Streptococcus. Clin Microbiol Rev. 27(2):264–301. doi:10.1128/CMR.00101-13.
   PubMed Web of Science ®Google Scholar
• Wolfmeier H, Schoenauer R, Atanassoff A, Neil D, Kadioglu A, Draeger A, Babiychuk E. 2015. Ca2+-dependent repair of pneumolysin pores: A new paradigm for host cellular defense against bacterial pore-forming toxins. Biochim Biophys Acta. 1853(9):2045–2054. doi:10.1016/j.bbamcr.2014.09.005.
   PubMed Web of Science ®Google Scholar
• Yipp BG, Petri B, Salina D, Jenne CN, Scott BNV, Zbytnuik LD, Pittman K, Asaduzzaman M, Wu K, Meijndert HC, et al. 2012. Dynamic NETosis is carried out by live neutrophils in human and mouse bacterial abscesses and during severe Gram-positive infection. Nat Med. 18(9):1386–1393. doi:10.1038/nm.2847.
   PubMed Web of Science ®Google Scholar
• Zhu L, Randall R, Lee J, Porter A, DeLeo F, Musser J. 2017. Contribution of secreted NADase and streptolysin O to the pathogenesis of epidemic serotype M1 Streptococcus pyogenes infections. Am J Pathol. 187(3):605–613. doi:10.1016/j.ajpath.2016.11.003.
   PubMed Web of Science ®Google Scholar